These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32479862)

  • 1. Identification of functional epitopes of structural proteins and in-silico designing of dual acting multiepitope anti-tick vaccine against emerging Crimean-Congo hemorrhagic fever virus.
    Shrivastava N; Verma A; Dash PK
    Eur J Pharm Sci; 2020 Aug; 151():105396. PubMed ID: 32479862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
    Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
    Front Immunol; 2021; 12():669812. PubMed ID: 34220816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever.
    Alam R; Samad A; Ahammad F; Nur SM; Alsaiari AA; Imon RR; Talukder MEK; Nain Z; Rahman MM; Mohammad F; Karpiński TM
    BMC Med; 2023 Feb; 21(1):36. PubMed ID: 36726141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single mutation in Crimean-Congo hemorrhagic fever virus discovered in ticks impairs infectivity in human cells.
    Hua BL; Scholte FE; Ohlendorf V; Kopp A; Marklewitz M; Drosten C; Nichol ST; Spiropoulou C; Junglen S; Bergeron É
    Elife; 2020 Oct; 9():. PubMed ID: 33084573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.
    Omoniyi AA; Adebisi SS; Musa SA; Nzalak JO; Bauchi ZM; Bako KW; Olatomide OD; Zachariah R; Nyengaard JR
    Sci Rep; 2022 May; 12(1):8736. PubMed ID: 35610299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus.
    Spengler JR; Estrada-Peña A; Garrison AR; Schmaljohn C; Spiropoulou CF; Bergeron É; Bente DA
    Antiviral Res; 2016 Nov; 135():31-47. PubMed ID: 27713073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Crimean-Congo hemorrhagic fever].
    Masayuki S
    Nihon Rinsho; 2016 Dec; 74(12):2003-2007. PubMed ID: 30550657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and phylogenetic analysis of Crimean-Congo hemorrhagic fever virus in ticks collected from Punjab province of Pakistan.
    Shahid MF; Yaqub T; Ali M; Ul-Rahman A; Bente DA
    Acta Trop; 2021 Jun; 218():105892. PubMed ID: 33753031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
    Keshtkar-Jahromi M; Kuhn JH; Christova I; Bradfute SB; Jahrling PB; Bavari S
    Antiviral Res; 2011 May; 90(2):85-92. PubMed ID: 21362441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Multi-epitope Based Subunit Vaccine Against Crimean-Congo Hemorrhagic Fever Virus Using Reverse Vaccinology Approach.
    Imran MA; Islam MR; Saha A; Ferdousee S; Mishu MA; Ghosh A
    Int J Pept Res Ther; 2022; 28(4):124. PubMed ID: 35789799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crimean-Congo hemorrhagic fever.
    Whitehouse CA
    Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
    Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
    BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.
    Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R
    Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus.
    Khan MSA; Nain Z; Syed SB; Abdulla F; Moni MA; Sheam MM; Karim MM; Adhikari UK
    Mol Cell Probes; 2021 Feb; 55():101693. PubMed ID: 33388416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoinformatics guided modeling of CCHF_GN728, an mRNA-based universal vaccine against Crimean-Congo hemorrhagic fever virus.
    Shahrear S; Islam ABMMK
    Comput Biol Med; 2022 Jan; 140():105098. PubMed ID: 34875407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crimean-Congo Hemorrhagic Fever.
    Shayan S; Bokaean M; Shahrivar MR; Chinikar S
    Lab Med; 2015; 46(3):180-9. PubMed ID: 26199256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.